FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Confirms Pfizer 95% Covid Vaccine Efficacy

[ Price : $8.95]

FDA advisory committee briefing information confirms 95% efficacy with Pfizer-BioNTechs Covid-19 vaccine.

Zebra Medical Orthopedic Surgical Planner Cleared

[ Price : $8.95]

FDA clears a Zebra Medical Vision 510(k) for its artificial intelligence analytics that extract bone measurements from X-ray scans...

Juno Therapeutics FDA-483

[ Price : $8.95]

FDA publishes the FDA-483 with six inspection observations issued to Juno Therapeutics.

Proprietary Name Guidances

[ Price : $8.95]

FDA issues guidances with recommended best practices to use in developing proprietary names for human prescription and non-prescri...

Administration Argues Covid Not Risky for Abortion Pill Patients: ACLU

[ Price : $8.95]

The ACLU says federal courts should continue to block an FDA policy requiring patients seeking mifepristone to appear in person at...

38 Project Orbis Approvals in First Full Year

[ Price : $8.95]

FDA says the Oncology Center of Excellences Project Orbis received 60 applications in its first full year of existence and approve...

Turning Point Breakthrough Status for Lung Cancer Drug

[ Price : $8.95]

FDA grants Turning Point Therapeutics a breakthrough therapy designation for repotrectinib and its use in treating certain patient...

Latest FDA Warning Letters

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that include Natures Boost and Valentus.

Priority Review Voucher Awarded to Y-mAbs Therapeutics

[ Price : $8.95]

Federal Register notice: FDA announces that Y-mAbs Therapeutics was awarded a priority review voucher related to the approval of D...

FDA Testing Annotated Electrocardiogram eSubmissions

[ Price : $8.95]

FDA tests its capability to receive annotated electrocardiogram waveform data in electronic format under the Health Level Seven (H...